Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-17-004025
Filing Date
2017-10-17
Accepted
2017-10-17 16:06:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCICLONE PHARMACEUTICALS, INC. p17-2081sc13da.htm SC 13D/A 31347
  Complete submission text file 0000902664-17-004025.txt   32788
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43408 | Film No.: 171140796
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD
Business Address RIVERBANK HOUSE, 2 SWAN LANE LONDON X0 EC4R 3AD 44 202 7144 1000
Man Group plc (Filed by) CIK: 0001637460 (see all company filings)

EIN.: 000000000
Type: SC 13D/A